Onderneming Bioblast Pharma Ltd Nasdaq
Aandelen
IL0011319527
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 16-11-19 |
Dror Mevorach
FOU | Founder | 68 | 01-01-09 |
Director of Finance/CFO | 47 | 01-01-16 | |
Chief Operating Officer | - | - | |
Sigal Arad
HRO | Human Resources Officer | - | - |
Iris Tavor
LAW | General Counsel | - | - |
Einat Galamidi
PRN | Corporate Officer/Principal | - | 22-02-22 |
Oren Elmaliah
AUD | Comptroller/Controller/Auditor | 40 | 01-02-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 01-01-14 |
Avri Havron
BRD | Director/Board Member | 76 | 01-01-14 |
Brian Schwartz
BRD | Director/Board Member | 52 | 01-12-20 |
Roger Pomerantz
BRD | Director/Board Member | 67 | 23-05-22 |
Gili Hart
BRD | Director/Board Member | 49 | 01-01-14 |
Andrew Singer
BRD | Director/Board Member | 53 | 17-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 658 555 | 18 008 736 ( 87,17 %) | 0 | 87,17 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 122 mld. | |
+21,96% | 116 mld. | |
+23,73% | 27,03 mld. | |
-20,05% | 20,36 mld. | |
-16,28% | 15,91 mld. | |
-16,52% | 16,43 mld. | |
-44,35% | 15,6 mld. | |
+63,91% | 14,94 mld. | |
+2,52% | 13,59 mld. |